RICHMOND, British Columbia, Sept. 20, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) CEO Dr. Ricardo Moro recently presented at the meeting of the International Society of Oncology and BioMarkers (ISOBM) held on Sept. 10, 2010 in Munich, Germany. The meeting was broadly attended by scientists, physicians and biotechnology companies involved in cancer diagnostics. Dr. Moro made two presentations related to the Company’s broad spectrum cancer marker, RECAF™, that is increased in the blood of cancer patients.
